XML 37 R25.htm IDEA: XBRL DOCUMENT
v3.21.2

Segment Reporting | 6 Months Ended
--- | ---
Jun. 30, 2021
Segment Reporting [Abstract] |
Segment Reporting | SEGMENT REPORTING Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include diagnostic and information technology-based products and services for the veterinary market, which we refer to as the Companion Animal Group (“CAG”), water quality products (“Water”) and diagnostic products and services for livestock and poultry health and to ensure the quality and safety of milk and improve dairy efficiency, which we refer to as Livestock, Poultry and Dairy (“LPD”). Although our LPD segment does not meet the quantitative thresholds to be reported as a separate segment, we believe it is important to disaggregate these revenues as a major product and service category within our Other reportable segment given its distinct markets, and therefore we have elected to report LPD as a reportable segment. Our Other operating segment combines and presents products and services for the human medical diagnostics (“OPTI Medical”) market with our out-licensing arrangements. Assets are not allocated to segments for internal reporting purposes. The following is a summary of segment performance:
(in thousands) |  | For the Three Months Ended June 30,
|  | CAG |  | Water |  | LPD |  | Other |  | Consolidated Total
2021 |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 745,595 |  |  | $ | 37,191 |  |  | $ | 33,524 |  |  | $ | 9,832 |  |  | $ | 826,142 |
Income from operations |  | $ | 234,735 |  |  | $ | 17,228 |  |  | $ | 6,868 |  |  | $ | 422 |  |  | $ | 259,253 |
Interest expense, net |  |  |  |  |  |  |  |  |  | (7,522) |
Income before provision for income taxes |  |  |  |  |  |  |  |  |  | 251,731 |
Provision for income taxes |  |  |  |  |  |  |  |  |  | 49,125 |
Net income |  |  |  |  |  |  |  |  |  | 202,606 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  | 24 |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  | $ | 202,582 |
2020 |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 566,100 |  |  | $ | 28,116 |  |  | $ | 32,244 |  |  | $ | 11,132 |  |  | $ | 637,592 |
Income from operations |  | $ | 167,969 |  |  | $ | 12,258 |  |  | $ | 8,249 |  |  | $ | 4,772 |  |  | $ | 193,248 |
Interest expense, net |  |  |  |  |  |  |  |  |  | (9,426) |
Income before provision for income taxes |  |  |  |  |  |  |  |  |  | 183,822 |
Provision for income taxes |  |  |  |  |  |  |  |  |  | 34,826 |
Net income |  |  |  |  |  |  |  |  |  | 148,996 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  | 56 |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  | $ | 148,940 |
(in thousands) |  | For the Six Months Ended June 30,
|  | CAG |  | Water |  | LPD |  | Other |  | Consolidated Total
2021 |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 1,438,362 |  |  | $ | 71,231 |  |  | $ | 72,794 |  |  | $ | 21,462 |  |  | $ | 1,603,849 |
Income from operations |  | $ | 447,945 |  |  | $ | 32,000 |  |  | $ | 20,676 |  |  | $ | 6,254 |  |  | $ | 506,875 |
Interest expense, net |  |  |  |  |  |  |  |  |  | (15,054) |
Income before provision for income taxes |  |  |  |  |  |  |  |  |  | 491,821 |
Provision for income taxes |  |  |  |  |  |  |  |  |  | 84,926 |
Net income |  |  |  |  |  |  |  |  |  | 406,895 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  | 56 |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  | $ | 406,839 |
2020 |  |  |  |  |  |  |  |  |  |
Revenue |  | $ | 1,118,096 |  |  | $ | 62,265 |  |  | $ | 66,398 |  |  | $ | 17,169 |  |  | $ | 1,263,928 |
Income from operations |  | $ | 286,628 |  |  | $ | 28,140 |  |  | $ | 17,912 |  |  | $ | 4,893 |  |  | $ | 337,573 |
Interest expense, net |  |  |  |  |  |  |  |  |  | (16,978) |
Income before provision for income taxes |  |  |  |  |  |  |  |  |  | 320,595 |
Provision for income taxes |  |  |  |  |  |  |  |  |  | 59,743 |
Net income |  |  |  |  |  |  |  |  |  | 260,852 |
Less: Net income attributable to noncontrolling interest |  |  |  |  |  |  |  |  |  | 85 |
Net income attributable to IDEXX Laboratories, Inc. stockholders |  |  |  |  |  |  |  |  |  | $ | 260,767 |
See “Note 3. Revenue Recognition” for a summary of disaggregated revenue by reportable segment and by major product and service category for the three and six months ended June 30, 2021 and 2020.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration